Safer Aging With Diabetes Monitoring

Description

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Conditions

Diabetes Mellitus, Type 2, Hypoglycemia

Study Overview

Study Details

Study overview

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes

Safer Aging With Diabetes Monitoring

Condition
Diabetes Mellitus, Type 2
Intervention / Treatment

-

Contacts and Locations

Fremont

Kaiser Permanente Fremont, Fremont, California, United States, 94538

San Leandro

Kaiser Permanente San Leandro, San Leandro, California, United States, 94577

Union City

Kaiser Permanente - Union City, Union City, California, United States, 94587

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 75 years and older
  • * Diagnosis of Type 2 Diabetes
  • * Current treatment with insulin
  • * Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)
  • * Able to communicate in English
  • * Able to access email and the Internet
  • * On renal dialysis
  • * Dementia
  • * Pacemaker or Automatic Implantable Cardioverter Defibrillator
  • * Using insulin pump
  • * Severe Mental Illness
  • * Severe Visual Impairment
  • * In Hospice
  • * Current or recent CGM use

Ages Eligible for Study

75 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Kaiser Permanente,

Richard W Grant, MD MPH, PRINCIPAL_INVESTIGATOR, Kaiser Permanente Northern California - Division of Research

Study Record Dates

2028-01-31